Home > > > > Report Detail

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 16-Nov-2023
No. of pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market:

According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biosimilar Monoclonal Antibodies market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Biosimilar Monoclonal Antibodies Market Report:

Market Size Estimates: Biosimilar Monoclonal Antibodies market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Biosimilar Monoclonal Antibodies market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Biosimilar Monoclonal Antibodies market

Segment Market Analysis: Biosimilar Monoclonal Antibodies market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Biosimilar Monoclonal Antibodies market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Biosimilar Monoclonal Antibodies Market: Revenue and sales volume of major countries in each region

Biosimilar Monoclonal Antibodies Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Biosimilar Monoclonal Antibodies market in major regions.

Biosimilar Monoclonal Antibodies Industry Value Chain: Biosimilar Monoclonal Antibodies market raw materials & suppliers, manufacturing process, distributors, downstream customers

Biosimilar Monoclonal Antibodies Industry News, Policies & Regulations

Key players in the global Biosimilar Monoclonal Antibodies market are covered in Chapter 12:

Amgen

Hospira

Sandoz

Celltrion

Samsung

Dr Reddy's

Boehringer Ingelheim

Zydus

Shanghai CP Guojian Pharmaceutical

In Chapter 2 and Chapter 15.1, based on types, the Biosimilar Monoclonal Antibodies market from 2018 to 2028 is primarily split into:

Infliximab

Rituximab

Trastuzumab

Adalimumab

Other

In Chapter 3 and Chapter 15.2, based on applications, the Biosimilar Monoclonal Antibodies market from 2018 to 2028 covers:

Oncology

Autoimmune Disease

Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Biosimilar Monoclonal Antibodies market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Biosimilar Monoclonal Antibodies Market Size (2018-2028)
1.3.1 Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Biosimilar Monoclonal Antibodies Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Biosimilar Monoclonal Antibodies Historic Revenue ($) by Type (2018-2023)
2.2 Global Biosimilar Monoclonal Antibodies Historic Sales Volume by Type (2018-2023)
2.3 Infliximab Sales and Price (2018-2023)
2.4 Rituximab Sales and Price (2018-2023)
2.5 Trastuzumab Sales and Price (2018-2023)
2.6 Adalimumab Sales and Price (2018-2023)
2.7 Other Sales and Price (2018-2023)

3 Global Biosimilar Monoclonal Antibodies Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Biosimilar Monoclonal Antibodies Historic Revenue ($) by Application (2018-2023)
3.2 Global Biosimilar Monoclonal Antibodies Historic Sales Volume by Application (2018-2023)
3.3 Oncology Sales, Revenue and Growth Rate (2018-2023)
3.4 Autoimmune Disease Sales, Revenue and Growth Rate (2018-2023)
3.5 Other Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Biosimilar Monoclonal Antibodies Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Biosimilar Monoclonal Antibodies Industry News
4.7.2 Biosimilar Monoclonal Antibodies Industry Policies

5 Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Biosimilar Monoclonal Antibodies Sales Volume by Region (2018-2023)
5.2 Global Biosimilar Monoclonal Antibodies Market Revenue ($) by Region (2018-2023)

6 Global Biosimilar Monoclonal Antibodies Import Volume and Export Volume by Major Regions
6.1 Global Biosimilar Monoclonal Antibodies Import Volume by Region (2018-2023)
6.2 Global Biosimilar Monoclonal Antibodies Export Volume by Region (2018-2023)

7 North America Biosimilar Monoclonal Antibodies Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
7.2 North America Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
7.3 North America Biosimilar Monoclonal Antibodies Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Biosimilar Monoclonal Antibodies Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Biosimilar Monoclonal Antibodies Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)

9 Europe Biosimilar Monoclonal Antibodies Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
9.2 Europe Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
9.3 Europe Biosimilar Monoclonal Antibodies Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)

10 Latin America Biosimilar Monoclonal Antibodies Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
10.3 Latin America Biosimilar Monoclonal Antibodies Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Biosimilar Monoclonal Antibodies Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Biosimilar Monoclonal Antibodies Revenue ($) and Market Share of Key Players
12.1.2 Global Biosimilar Monoclonal Antibodies Sales Volume and Market Share of Key Players
12.1.3 Global Biosimilar Monoclonal Antibodies Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Amgen Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Hospira Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Hospira Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Sandoz Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Sandoz Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Celltrion Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Celltrion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Samsung Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Samsung Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Dr Reddy's Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Dr Reddy's Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Boehringer Ingelheim Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Boehringer Ingelheim Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Zydus Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Zydus Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Shanghai CP Guojian Pharmaceutical Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Shanghai CP Guojian Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Biosimilar Monoclonal Antibodies Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
13.3.3 Raw Material Cost of Biosimilar Monoclonal Antibodies
13.3.4 Labor Cost of Biosimilar Monoclonal Antibodies
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Biosimilar Monoclonal Antibodies Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Type (2023-2028)
15.2 Global Biosimilar Monoclonal Antibodies Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Application (2023-2028)
15.3 Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Region (2023-2028)
15.4 Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Picture
Table Biosimilar Monoclonal Antibodies Definition
Table Description and Definitions
Figure Infliximab Features
Figure Rituximab Features
Figure Trastuzumab Features
Figure Adalimumab Features
Figure Other Features
Table Description and Definitions
Figure Oncology
Figure Autoimmune Disease
Figure Other
Figure North America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Europe Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2028)
Figure Global Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2028)
Table Global Biosimilar Monoclonal Antibodies Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Historic Revenue ($) Share by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Historic Sales Volume by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Historic Sales Volume Share by Type (2018-2023)
Figure Global Infliximab Sales and Growth Rate (2018-2023)
Figure Global Infliximab Price (2018-2023)
Figure Global Rituximab Sales and Growth Rate (2018-2023)
Figure Global Rituximab Price (2018-2023)
Figure Global Trastuzumab Sales and Growth Rate (2018-2023)
Figure Global Trastuzumab Price (2018-2023)
Figure Global Adalimumab Sales and Growth Rate (2018-2023)
Figure Global Adalimumab Price (2018-2023)
Figure Global Other Sales and Growth Rate (2018-2023)
Figure Global Other Price (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Historic Revenue ($) Share by Application (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Historic Sales Volume Share by Application (2018-2023)
Figure Global Oncology Sales and Growth Rate (2018-2023)
Figure Global Oncology Revenue and Growth Rate (2018-2023)
Figure Global Autoimmune Disease Sales and Growth Rate (2018-2023)
Figure Global Autoimmune Disease Revenue and Growth Rate (2018-2023)
Figure Global Other Sales and Growth Rate (2018-2023)
Figure Global Other Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Biosimilar Monoclonal Antibodies Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Biosimilar Monoclonal Antibodies Sales Volume by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Share by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Market Revenue ($) by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Market Revenue ($) Share by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Import Volume by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Export Volume by Region (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
Table North America Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
Table North America Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Table North America Biosimilar Monoclonal Antibodies Sales Volume by Country (2018-2023)
Figure United States Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Canada Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Volume by Country (2018-2023)
Figure China Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Japan Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure India Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Figure Australia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
Table Europe Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Sales Volume by Country (2018-2023)
Figure Germany Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure France Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Italy Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Spain Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Russia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Poland Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
Table Latin America Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
Table Latin America Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Table Latin America Biosimilar Monoclonal Antibodies Sales Volume by Country (2018-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Market Trends Analysis Under Global Inflation
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue ($) by Country (2018-2023)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Volume by Country (2018-2023)
Figure GCC Countries Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Figure Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) of Key Players (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Share of Key Players (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Volume of Key Players (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Share of Key Players (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Amgen Company Profiles
Table Product Profiles and Application
Table Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2018-2023
Table Hospira Company Profiles
Table Product Profiles and Application
Table Hospira Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Hospira Production and Growth Rate
Figure Hospira Value ($) Market Share 2018-2023
Table Sandoz Company Profiles
Table Product Profiles and Application
Table Sandoz Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sandoz Production and Growth Rate
Figure Sandoz Value ($) Market Share 2018-2023
Table Celltrion Company Profiles
Table Product Profiles and Application
Table Celltrion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2018-2023
Table Samsung Company Profiles
Table Product Profiles and Application
Table Samsung Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Samsung Production and Growth Rate
Figure Samsung Value ($) Market Share 2018-2023
Table Dr Reddy's Company Profiles
Table Product Profiles and Application
Table Dr Reddy's Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Dr Reddy's Production and Growth Rate
Figure Dr Reddy's Value ($) Market Share 2018-2023
Table Boehringer Ingelheim Company Profiles
Table Product Profiles and Application
Table Boehringer Ingelheim Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2018-2023
Table Zydus Company Profiles
Table Product Profiles and Application
Table Zydus Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Zydus Production and Growth Rate
Figure Zydus Value ($) Market Share 2018-2023
Table Shanghai CP Guojian Pharmaceutical Company Profiles
Table Product Profiles and Application
Table Shanghai CP Guojian Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Shanghai CP Guojian Pharmaceutical Production and Growth Rate
Figure Shanghai CP Guojian Pharmaceutical Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Biosimilar Monoclonal Antibodies
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Biosimilar Monoclonal Antibodies with Contact Information
Figure Production Process of Biosimilar Monoclonal Antibodies
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Table Major Distributors of Biosimilar Monoclonal Antibodies with Contact Information
Table Major Downstream Buyers of Biosimilar Monoclonal Antibodies with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Share Forecast by Type (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Share Forecast by Type (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Share Forecast by Application (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Share Forecast by Application (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Region (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Sales Volume Share Forecast by Region (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Forecast by Region (2023-2028)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) Share Forecast by Region (2023-2028)
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs